#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistance

Antimicrobial resistance (AMR) continues to serve as a major global health crisis. Clinicians practising in this modern era are faced with ongoing challenges in the therapeutic management of patients suffering from antimicrobial-resistant infections. A strong educational understanding and synergistic application of clinical microbiology, infectious disease and pharmacological concepts can assist the adventuring clinician in the navigation of such cases. Important items include mobilizing laboratory testing for pathogen identification and susceptibility data, harnessing an understanding of intrinsic pathogen resistance, acknowledging epidemiological resistance trends, recognizing acquired AMR mechanisms, and consolidating these considerations when constructing an ideal pharmacological plan. In this article, we outline a novel framework by which to systematically approach clinical AMR, encourage AMR-related education and optimize therapeutic decision-making in AMR-related illnesses.

Automated summary

Antimicrobial resistance (AMR) is a global health crisis. Clinicians face challenges in treating patients with antimicrobial-resistant infections. A strong understanding of clinical microbiology, infectious diseases, and pharmacology can help clinicians navigate these cases. Important factors include laboratory testing, understanding pathogen resistance, recognizing resistance trends, identifying acquired AMR mechanisms, and considering these factors for an optimal pharmacological plan. This article outlines a novel framework for approaching clinical AMR, encourages education on AMR, and improves therapeutic decision-making in AMR-related illnesses.